CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease (original) (raw)

• Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
  Article CAS Google Scholar
• Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003).
  Article CAS Google Scholar
• van Duivenvoorde, L.M., van Mierlo, G.J., Boonman, Z.F. & Toes, R.E. Dendritic cells: vehicles for tolerance induction and prevention of autoimmune diseases. Immunobiology 211, 627–632 (2006).
  Article CAS Google Scholar
• Morelli, A.E. & Thomson, A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7, 610–621 (2007).
  Article CAS Google Scholar
• Charbonnier, L.M. et al. Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells. J. Immunol. 177, 3806–3813 (2006).
  Article CAS Google Scholar
• Fu, F. et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86−) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62, 659–665 (1996).
  Article CAS Google Scholar
• Rastellini, C. et al. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60, 1366–1370 (1995).
  CAS PubMed PubMed Central Google Scholar
• Kim, S.H. et al. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J. Immunol. 166, 3499–3505 (2001).
  Article CAS Google Scholar
• Kim, S.H., Kim, S., Oligino, T.J. & Robbins, P.D. Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL. Mol. Ther. 6, 584–590 (2002).
  Article CAS Google Scholar
• Morelli, A.E. & Thomson, A.W. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196, 125–146 (2003).
  Article CAS Google Scholar
• Hackstein, H. & Thomson, A.W. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 4, 24–34 (2004).
  Article CAS Google Scholar
• Sato, K., Yamashita, N., Yamashita, N., Baba, M. & Matsuyama, T. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18, 367–379 (2003).
  Article CAS Google Scholar
• O'Connell, P.J. et al. Immature and mature CD8α+ dendritic cells prolong the survival of vascularized heart allografts. J. Immunol. 168, 143–154 (2002).
  Article CAS Google Scholar
• Liu, Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275–306 (2005).
  Article CAS Google Scholar
• Colonna, M., Trinchieri, G. & Liu, Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219–1226 (2004).
  Article CAS Google Scholar
• Kuwana, M., Kaburaki, J., Wright, T.M., Kawakami, Y. & Ikeda, Y. Induction of antigen-specific human CD4+ T cell anergy by peripheral blood DC2 precursors. Eur. J. Immunol. 31, 2547–2557 (2001).
  Article CAS Google Scholar
• Martin, P. et al. Characterization of a new subpopulation of mouse CD8α+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 100, 383–390 (2002).
  Article CAS Google Scholar
• Bilsborough, J., George, T.C., Norment, A. & Viney, J.L. Mucosal CD8α+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 108, 481–492 (2003).
  Article CAS Google Scholar
• Arpinati, M. et al. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation. Transpl. Immunol. 11, 345–356 (2003).
  Article CAS Google Scholar
• Fugier-Vivier, I.J. et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201, 373–383 (2005).
  Article CAS Google Scholar
• Abe, M., Wang, Z., de Creus, A. & Thomson, A.W. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5, 1808–1819 (2005).
  Article CAS Google Scholar
• Kohrgruber, N. et al. Survival, maturation, and function of CD11c− and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J. Immunol. 163, 3250–3259 (1999).
  CAS PubMed Google Scholar
• Kuwana, M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum. Immunol. 63, 1156–1163 (2002).
  Article CAS Google Scholar
• Kunkel, E.J. et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: Epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192, 761–768 (2000).
  Article CAS Google Scholar
• Uehara, S., Grinberg, A., Farber, J.M. & Love, P.E. A role for CCR9 in T lymphocyte development and migration. J. Immunol. 168, 2811–2819 (2002).
  Article CAS Google Scholar
• Salmi, M. & Jalkanen, S. Lymphocyte homing to the gut: attraction, adhesion, and commitment. Immunol. Rev. 206, 100–113 (2005).
  Article CAS Google Scholar
• Campbell, D.J. & Butcher, E.C. Rapid acquisition of tissue-specific homing phenotypes by CD4+ T cells activated in cutaneous or mucosal lymphoid tissues. J. Exp. Med. 195, 135–141 (2002).
  Article CAS Google Scholar
• Gilliet, M. et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953–958 (2002).
  Article CAS Google Scholar
• Vanbervliet, B. et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198, 823–830 (2003).
  Article CAS Google Scholar
• Caux, C. et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22, 345–369 (2000).
  Article CAS Google Scholar
• Dieu, M.C. et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373–386 (1998).
  Article CAS Google Scholar
• Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M. & Murphy, K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688 (2006).
  Article CAS Google Scholar
• Stockinger, B. & Veldhoen, M. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19, 281–286 (2007).
  Article CAS Google Scholar
• Wendland, M. et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. USA 104, 6347–6352 (2007).
  Article CAS Google Scholar
• Wurbel, M.A. et al. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur. J. Immunol. 30, 262–271 (2000).
  Article CAS Google Scholar
• Zabel, B.A. et al. Human G protein-coupled receptor GPR-9–6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J. Exp. Med. 190, 1241–1256 (1999).
  Article CAS Google Scholar
• Pabst, O. et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J. Exp. Med. 199, 411–416 (2004).
  Article CAS Google Scholar
• Bonasio, R. et al. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol. 7, 1092–1100 (2006).
  Article CAS Google Scholar
• Zeng, D. et al. Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation. Blood 99, 1449–1457 (2002).
  Article CAS Google Scholar
• Hoffmann, P., Ermann, J., Edinger, M., Fathman, C.G. & Strober, S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 196, 389–399 (2002).
  Article CAS Google Scholar
• Cohen, J.L., Trenado, A., Vasey, D., Klatzmann, D. & Salomon, B.L. CD4+CD25+ immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196, 401–406 (2002).
  Article CAS Google Scholar
• Lohr, J., Knoechel, B., Wang, J.J., Villarino, A.V. & Abbas, A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 203, 2785–2791 (2006).
  Article CAS Google Scholar
• Murphy, W.J. et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Clin. Invest. 102, 1742–1748 (1998).
  Article CAS Google Scholar
• Yang, Y.G., Dey, B.R., Sergio, J.J., Pearson, D.A. & Sykes, M. Donor-derived interferon γ is required for inhibition of acute graft-versus-host disease by interleukin 12. J. Clin. Invest. 102, 2126–2135 (1998).
  Article CAS Google Scholar
• Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Article CAS Google Scholar
• Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
  Article CAS Google Scholar
• Morel, P.A., Vasquez, A.C. & Feili-Hariri, M. Immunobiology of DC in NOD mice. J. Leukoc. Biol. 66, 276–280 (1999).
  Article CAS Google Scholar
• Feili-Hariri, M. et al. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 48, 2300–2308 (1999).
  Article CAS Google Scholar
• Popov, I. et al. Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res. Ther. 8, R141 (2006).
  Article Google Scholar
• Hochweller, K. & Anderton, S.M. Systemic administration of antigen-loaded CD40-deficient dendritic cells mimics soluble antigen administration. Eur. J. Immunol. 34, 990–998 (2004).
  Article CAS Google Scholar
• Maraskovsky, E. et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953–1962 (1996).
  Article CAS Google Scholar
• Asselin-Paturel, C. et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144–1150 (2001).
  Article CAS Google Scholar
• O'Keeffe, M. et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8+ dendritic cells only after microbial stimulus. J. Exp. Med. 196, 1307–1319 (2002).
  Article CAS Google Scholar
• Mach, N. et al. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60, 3239–3246 (2000).
  CAS PubMed Google Scholar